All cancer types
Open
Phase 2
This trial is looking at whether a drug called metformin might reduce the risk of cancer developing in people with Li Fraumeni Syndrome.
(LFS) is an inherited condition. People who have LFS have an increased risk of developing different types of cancer.
Recruitment start: 20 December 2023
Recruitment end: 31 December 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Sarah Blagden
Cancer Research UK
The George Pantziarka TP53 Trust
Medical Research Council (MRC)
National Institute for Health & Care Research (NIHR)
Oxford Clinical Trials Research Unit (OCTRU)
Oncology Clinical Trials Office (OCTO)
University of Oxford
Last reviewed: 03 Apr 2025
CRUK internal database number: 19461
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
